CONSIDER MAGNESIUM HOMEOSTASIS .3. CYTOCHROME-P450 ENZYMES AND DRUG TOXICITY

The serum contains only 0.3% of the body's magnesium (sMg). More than half is in bone and nearly half is intracellular. The bone Mg is in eq uilibrium with sMg, whereas red blood cell Mg (rbcMg) reflects sMg con centration while each cell is maturing. The kidney controls the sMg by reabsorption up to a serum level of 3mg/dL, and the amount saved vari es with the Mg balance. Normal humans retain less than 25% of an intra venous Mg load test. When the sMg is normal and the load test and/or r bcMg values are abnormal, normomagnesemia Mg deficiency (MgD), Type 1, exists. The earliest stage is latent MgD, which has been defined as m ore than 25% but less than 50% retention of Mg in a load test. In thos e with more severe stages of MgD, the Mg retention is more than 50%. O ccult MgD is when there is more than 50% retention. Whenever the rbcMg level is also decreased, subclinical MgD is present. Type II MgD is c learly understood by everyone, because of the presence of hypomagnesem ia. There are multiple causes of minimal urinary Mg wasting, plus othe r causes of MgD, and there are many subtle symptoms of MgD. Over 300 e nzyme systems require Mg to function optimally, including the cytochro me P450 enzymes (CYP450). In vitro evaluation of CYP450 metabolism of drugs require a NADPH-generating system, which contains MgCl2 and requ ires NADPH cytochrome P450 reductase. NADPH-CYP450-reductase also requ ires Mg. Drug toxicity might well be due, in part, to CYP450 enzymes n ot being in an adequate environment when MgD is present. Symptoms and signs of both noncardiac and cardiotoxic drug reactions to theophyllin e and some of the second-generation antihistamines are similar to thos e found in MgD. MgD is a known risk factor for torsades de pointes TdP , which has been treated with Mg sulfate. Moreover, many of the causes of MgD are present in patients with drug intolerance. A comprehensive evaluation of Mg status should be done in all patients with drug reac tions when CYP450 enzymes are involved, before, during and after inter vention. This should include a sMg, rbcMg, and a 24-hour urine Mg leve ls. A urine creatinine/Mg ratio should be calculated using 24-hour uri ne concentrations. The metabolism of these drugs need to be studied in a population of patients with known normomagnesemia MgD.